devices that integrate glp-1 schedules and glucose data Advances in receptor agonists delivery systems for obesity diabetes GLP-1 Receptor Agonists at the
Description
This study found no evidence reasonably suggesting an association between GLP-1RA and SSIBs based on clinical characteristics, TTO, disproportionality, and co-medication analysis
Gastrointestinal symptoms, such as nausea and vomiting, were the most frequently reported adverse events, particularly during the dose escalation phase
B.KramerM
Patient-Centered Guidance Educate on transient issues, track symptoms, and personalise plans
A diagnosis of DKD should only be made if repeat testing confirms an elevation in this ratio (greater than 2.5 mg/mmol in men or greater than 3.5 mg/mmol in women)
